Cipher Pharmaceuticals Inc

PHE

Company Profile

  • Business description

    Cipher Pharmaceuticals Inc is a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products. The Company is building its business through product acquisitions, out-licensing and in-licensing arrangements. Its products include Dermatology Products, Hospital Acute Care Products, specialty medicines, and Out-Licensed Products among others. The company's geographical operational areas include Canada and the United States.

  • Contact

    5750 Explorer Drive
    Suite 404
    MississaugaONL4W 0A9
    CAN

    T: +1 905 602-5840

    E: [email protected]

    https://www.cipherpharma.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2026

    Employees

    6

Stocks News & Analysis

stocks

Lower fair value on ASX best idea

Shares are still undervalued despite drop in profit margins.
stocks

We raise our near-term gold price assumptions

Our coverage remains overvalued.
stocks

Apple: Gemini partnership lets AI-worried investors breathe a sigh of relief

We believe a competitive—if not leading—AI feature suite will reinforce Apple’s wide-moat mobile device ecosystem.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,184.2027.30-0.30%
CAC 408,304.3526.61-0.32%
DAX 4025,254.2831.96-0.13%
Dow JONES (US)49,149.6342.36-0.09%
FTSE 10010,225.9341.580.41%
HKSE26,923.6276.19-0.28%
NASDAQ23,471.75238.13-1.00%
Nikkei 22554,110.50230.73-0.42%
NZX 50 Index13,659.7997.92-0.71%
S&P 5006,926.6037.14-0.53%
S&P/ASX 2008,861.7019.30-0.22%
SSE Composite Index4,112.6013.49-0.33%

Market Movers